Developer of genomics and bioinformatics platform designed to unify research over democratizing access to omics data. The company's platform offers reproducible and easy-to-share genomics analysis in a single click provides integration with free open-source analysis alongside a marketplace of proprietary alternatives and gives access to visualization of large data sets associated with human genome sequencing, enabling researchers to run complex analyses and generate meaningful insights and secure research over distributed big data.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Ionis is unlocking the rapidly expanding potential of RNA- and DNA-targeted medicines to enable better futures for people living with serious diseases.